Unani Concept of Maḍarrat and Tadbīr-i-Advia (Adverse Drug Effect and Detoxification): A Scientific Appraisal

Abstract Background: Unani medicine, such drugs are used after processing (detoxification), a procedure by which harmful elements are downgraded. The Unani concept of adverse drug effects and their downgrading before use is somehow vague for the present-day addressees because of subjective scales to enumerate the idea. Methodology: This study was designed to revisit the concept of scientific parameters. Pre- and post-processed samples of an Unani drug, Māzū Sabz , which is thought to be harmful as it is, were taken as an example and evaluated using physicochemical and analytical methods, such as spectrophotometry and high-performance liquid chromatography, to determine whether there are any differences between pre- and post-processed samples. Result: The study did not reveal clear results. The study revealed that the conventional concept of adverse drug effects and the Unani concept of Maḍarrat (adverse drug effect) are not the same. This study also explained that the processing of a drug ( Tadbīr-i-Advia ) does not always mean a major difference; rather, the purpose may also be, sometimes, otherwise. Conclusion: These findings underscore that the traditional Unani notion of Maḍarrat (adverse drug effect) differs from the modern concept of toxicity, and that the purpose of drug processing (Tadbīr-i-Advia) may extend beyond merely reducing harm—it is not always aimed at creating significant chemical alterations.